Clinical Research Directory

Inclusion Criteria: * Signed ICF prior to any study-mandated procedure. * Has received a first prescription of daridorexant 50 mg to treat insomnia, treatment start has not exceeded 7 days prior to enrollment. * Ability to read and understand French or English. Exclusion Criteria: * Patients participating in a clinical trial. * History of daridorexant use in the past (i.e., samples provided by the physician before prescription). * Taking a concomitant medication to treat insomnia. * Already started daridorexant more than 7 days prior to enrollment.The 7-day period is necessary to allow flexibility between the time of prescription and PROxy first contact to participant. Beyond this 7-day period, patients may already have experienced benefits from daridorexant. To minimize bias in baseline results, these patients will be excluded.